"Kids_First_Biospecimen_ID_DNA" "Kids_First_Biospecimen_ID_RNA" "gene_symbol" "cancer_group" "pathology_free_text_diagnosis" "copy_number" "MYCN_TPM" "status"
"1" "BS_0RBGK29M" "BS_KC02E200" "MYCN" "Neuroblastoma" NA 3 47.21 "gain"
"2" "BS_2FPVHEQS" "BS_GR7694W1" "MYCN" "Neuroblastoma" NA 145 404.76 "amplification"
"3" "BS_2P6MH05V" "TARGET-30-PATGLU-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 56.8 "gain"
"4" "BS_3564XTTK" "BS_3CSY3JTN" "MYCN" "Neuroblastoma" NA 647 375.71 "amplification"
"5" "BS_3AKS23A0" "BS_F2F7BXT5" "MYCN" "Neuroblastoma" NA 3 24.78 "gain"
"6" "BS_4J8JK335" "BS_H4TFY19Z" "MYCN" "Neuroblastoma" NA 5 96.4 "amplification"
"7" "BS_4NPEMNAD" "BS_DY88N5ZT" "MYCN" "Neuroblastoma" "Metastatic secondary tumors;Neuroblastoma" 100 83.29 "amplification"
"8" "BS_5BB8J64W" "BS_T7MWWC0A" "MYCN" "Neuroblastoma" NA 3 26.39 "gain"
"9" "BS_64P50TAP" "BS_CZMY8CVE" "MYCN" "Neuroblastoma" NA 3 42.78 "gain"
"10" "BS_76SQJSHP" "BS_BW9QBKEQ" "MYCN" "Neuroblastoma" NA 5 33.58 "gain"
"11" "BS_7BJQNVK8" "BS_EMBK3HHP" "MYCN" "Neuroblastoma" NA 3 17.84 "gain"
"12" "BS_8XDZQKSD" "BS_MPE34NYZ" "MYCN" "Neuroblastoma" "MYCN amp" 3 334.91 "gain"
"13" "BS_8XDZQKSD" "TARGET-30-PASWYR-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 3 1165.28 "gain"
"14" "BS_9ZDR2H7D" "BS_XZQE9FBM" "MYCN" "Neuroblastoma" NA 106 245.8 "amplification"
"15" "BS_A527Y2QF" "BS_S4WH99C9" "MYCN" "Neuroblastoma" NA 18 213.48 "amplification"
"16" "BS_A5AQFAFA" "BS_QJ3XB7XZ" "MYCN" "Ganglioneuroblastoma" NA 3 27.01 "gain"
"17" "BS_ACCE0MEA" "BS_94ZKC2SR" "MYCN" "Neuroblastoma" NA 3 269.8 "gain"
"18" "BS_AE718N55" "BS_ZWRZRC4V" "MYCN" "Neuroblastoma" NA 3 44.21 "gain"
"19" "BS_APY3G22J" "BS_A70FPYSH" "MYCN" "Neuroblastoma" NA 3 30.4 "gain"
"20" "BS_B2RYV4GG" "BS_S32M2YTY" "MYCN" "Neuroblastoma" NA 3 20.41 "gain"
"21" "BS_BF83XX7P" "BS_NJSZSZX5" "MYCN" "Neuroblastoma" NA 3 15.73 "gain"
"22" "BS_BTRGQHM4" "BS_HHNQ3N2V" "MYCN" "Neuroblastoma" NA 3 21.94 "gain"
"23" "BS_C2FYP4KW" "BS_H9BW7Y9C" "MYCN" "Neuroblastoma" NA 4 23.53 "gain"
"24" "BS_CD6KRB1K" "BS_GWN2F333" "MYCN" "Neuroblastoma" NA 3 25.93 "gain"
"25" "BS_CWPHVM94" "BS_48YZKWC2" "MYCN" "Neuroblastoma" NA 4 31.01 "gain"
"26" "BS_DGV11G69" "BS_RZEEJETF" "MYCN" "Neuroblastoma" NA 3 19.49 "gain"
"27" "BS_DWYR5CTE" "BS_W5X4568N" "MYCN" "Neuroblastoma" NA 132 290.47 "amplification"
"28" "BS_FAEHNS3Q" "BS_4JVC08W2" "MYCN" "Neuroblastoma" NA 3 21.71 "gain"
"29" "BS_FJP95JXF" "BS_ZFJS669M" "MYCN" "Neuroblastoma" NA 3 311.07 "gain"
"30" "BS_GZG7GH62" "BS_TT20NP68" "MYCN" "Neuroblastoma" NA 3 23.2 "gain"
"31" "BS_HZKJMB0D" "BS_YA56YE71" "MYCN" "Neuroblastoma" NA 29 74.25 "amplification"
"32" "BS_JV1GTZ1Q" "BS_82Q78622" "MYCN" "Neuroblastoma" NA 3 30.16 "gain"
"33" "BS_KP0YNTAK" "BS_1RT76ANT" "MYCN" "Neuroblastoma" "Metastatic secondary tumors;Neuroblastoma" 4 9.38 "gain"
"34" "BS_NVJJJ7MT" "BS_WKPG4MH1" "MYCN" "Neuroblastoma" NA 3 40.72 "gain"
"35" "BS_P0BHM8S1" "BS_CCV91DR0" "MYCN" "Neuroblastoma" NA 59 57.78 "amplification"
"36" "BS_QDRHQSPZ" "BS_6WBAV14H" "MYCN" "Neuroblastoma" NA 3 313.7 "gain"
"37" "BS_R13WNSAR" "BS_GMH5C45K" "MYCN" "Neuroblastoma" NA 54 345.49 "amplification"
"38" "BS_SMJRCVQB" "BS_0D3SCV7P" "MYCN" "Neuroblastoma" NA 3 8.29 "gain"
"39" "BS_SYSZCYYZ" "BS_97SKFHM4" "MYCN" "Neuroblastoma" NA 222 171.07 "amplification"
"40" "BS_T5BAS1JN" "BS_8MYS5HP4" "MYCN" "Neuroblastoma" NA 68 241.34 "amplification"
"41" "BS_T9VPRPVA" "BS_3KGHX57D" "MYCN" "Neuroblastoma" NA 3 19.69 "gain"
"42" "BS_TS07B3TC" "BS_5Z1QJPG6" "MYCN" "Neuroblastoma" NA 3 54.09 "gain"
"43" "BS_V4VGG98Y" "BS_EZRVK9ZQ" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 29.28 "gain"
"44" "BS_V4VGG98Y" "TARGET-30-PASXHE-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 82.16 "gain"
"45" "BS_WBZBDN0A" "BS_6YYC47K2" "MYCN" "Neuroblastoma" NA 4 36.01 "gain"
"46" "BS_WRZATZQF" "BS_JFJYEHFM" "MYCN" "Neuroblastoma" NA 3 16.22 "gain"
"47" "BS_X2D8S1HY" "BS_8VPBB5C2" "MYCN" "Neuroblastoma" NA 3 38.35 "gain"
"48" "BS_ZED6T1CT" "BS_896YFFGE" "MYCN" "Neuroblastoma" NA 30 75.36 "amplification"
"49" "TARGET-30-PAIFXV-01A-01D" "TARGET-30-PAIFXV-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 3.38 "gain"
"50" "TARGET-30-PAIPGU-01A-01W" "TARGET-30-PAIPGU-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 20.29 "gain"
"51" "TARGET-30-PAITCI-01A-01W" "TARGET-30-PAITCI-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 20.11 "loss"
"52" "TARGET-30-PAITEG-01A-01W" "TARGET-30-PAITEG-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 1.41 "neutral"
"53" "TARGET-30-PAIVHE-01A-01W" "TARGET-30-PAIVHE-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 45.8 "loss"
"54" "TARGET-30-PAKYZS-01A-01W" "TARGET-30-PAKYZS-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 10.09 "neutral"
"55" "TARGET-30-PALBFW-01A-01W" "TARGET-30-PALBFW-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 25.2 "neutral"
"56" "TARGET-30-PALCBW-01A-01W" "TARGET-30-PALCBW-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 3.82 "loss"
"57" "TARGET-30-PALETP-01A-01W" "TARGET-30-PALETP-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 38.47 "neutral"
"58" "TARGET-30-PALEVG-01A-01W" "TARGET-30-PALEVG-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 44 841.17 "amplification"
"59" "TARGET-30-PALIIN-01A-01W" "TARGET-30-PALIIN-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 65.69 "loss"
"60" "TARGET-30-PALTEG-01A-01W" "TARGET-30-PALTEG-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 20.09 "neutral"
"61" "TARGET-30-PALWVJ-01A-01W" "TARGET-30-PALWVJ-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 10.08 "neutral"
"62" "TARGET-30-PALZZV-01A-01W" "TARGET-30-PALZZV-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 86 888.26 "amplification"
"63" "TARGET-30-PAMMXF-01A-01W" "TARGET-30-PAMMXF-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 2 536 "neutral"
"64" "TARGET-30-PAMVRA-01A-01W" "TARGET-30-PAMVRA-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 65.33 "loss"
"65" "TARGET-30-PAMYCE-01A-01W" "TARGET-30-PAMYCE-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 26.63 "loss"
"66" "TARGET-30-PAMZGT-01A-01W" "TARGET-30-PAMZGT-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 23 238.17 "amplification"
"67" "TARGET-30-PAMZMG-01A-01W" "TARGET-30-PAMZMG-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 44 641.29 "amplification"
"68" "TARGET-30-PANBMJ-01A-01W" "TARGET-30-PANBMJ-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 3.78 "neutral"
"69" "TARGET-30-PANBSP-01A-01W" "TARGET-30-PANBSP-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 52.35 "neutral"
"70" "TARGET-30-PANKFE-01A-01W" "TARGET-30-PANKFE-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 4.74 "neutral"
"71" "TARGET-30-PANLET-01A-01D" "TARGET-30-PANLET-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 36.1 "loss"
"72" "TARGET-30-PANRHJ-01A-01W" "TARGET-30-PANRHJ-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 25.28 "neutral"
"73" "TARGET-30-PANRVJ-01A-01D" "TARGET-30-PANRVJ-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 30.22 "loss"
"74" "TARGET-30-PANSBN-01A-01D" "TARGET-30-PANSBN-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 0.74 "neutral"
"75" "TARGET-30-PANUIF-01A-01D" "TARGET-30-PANUIF-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 14.77 "gain"
"76" "TARGET-30-PANWRR-01A-01D" "TARGET-30-PANWRR-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 47.51 "neutral"
"77" "TARGET-30-PANXJL-01A-01D" "TARGET-30-PANXJL-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 1.77 "loss"
"78" "TARGET-30-PANYGR-01A-01W" "TARGET-30-PANYGR-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 36.9 "loss"
"79" "TARGET-30-PANZPV-01A-01W" "TARGET-30-PANZPV-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 12.32 "loss"
"80" "TARGET-30-PANZVU-01A-01W" "TARGET-30-PANZVU-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 41.2 "loss"
"81" "TARGET-30-PAPBGH-01A-01W" "TARGET-30-PAPBGH-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 0.51 "loss"
"82" "TARGET-30-PAPBJE-01A-01D" "TARGET-30-PAPBJE-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 216 794.4 "amplification"
"83" "TARGET-30-PAPBZI-01A-01W" "TARGET-30-PAPBZI-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 4 24.12 "gain"
"84" "TARGET-30-PAPCTS-01A-01D" "TARGET-30-PAPCTS-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 129 1730.92 "amplification"
"85" "TARGET-30-PAPEFE-01A-01W" "TARGET-30-PAPEFE-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 7 256.18 "amplification"
"86" "TARGET-30-PAPHPE-01A-01W" "TARGET-30-PAPHPE-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 6.75 "neutral"
"87" "TARGET-30-PAPKWN-01A-01W" "TARGET-30-PAPKWN-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 13 53.77 "amplification"
"88" "TARGET-30-PAPKXS-01A-01D" "TARGET-30-PAPKXS-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 156.12 "gain"
"89" "TARGET-30-PAPLSD-01A-01D" "TARGET-30-PAPLSD-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 27.18 "gain"
"90" "TARGET-30-PAPTAN-01A-01D" "TARGET-30-PAPTAN-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 17.55 "neutral"
"91" "TARGET-30-PAPTCR-01A-01D" "TARGET-30-PAPTCR-01A-01R" "MYCN" "Neuroblastoma" NA 2 6.25 "neutral"
"92" "TARGET-30-PAPTFZ-01A-01D" "TARGET-30-PAPTFZ-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 125 963.04 "amplification"
"93" "TARGET-30-PAPTLV-01A-01D" "TARGET-30-PAPTLV-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 24 287.38 "amplification"
"94" "TARGET-30-PAPUWY-01A-01D" "TARGET-30-PAPUWY-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 54.03 "loss"
"95" "TARGET-30-PAPVFD-01A-01D" "TARGET-30-PAPVFD-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 83.89 "loss"
"96" "TARGET-30-PAPVFD-01A-01D" "TARGET-30-PAPVFD-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 83.89 "neutral"
"97" "TARGET-30-PAPVFD-01A-01D" "TARGET-30-PAPVFD-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 83.89 "loss"
"98" "TARGET-30-PAPVFD-01A-01D" "TARGET-30-PAPVFD-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 83.89 "neutral"
"99" "TARGET-30-PAPVRN-01A-01D" "TARGET-30-PAPVRN-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 7.12 "loss"
"100" "TARGET-30-PAPVXS-01A-01D" "TARGET-30-PAPVXS-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 41.63 "neutral"
"101" "TARGET-30-PAPZYZ-01A-01D" "TARGET-30-PAPZYZ-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 131 297.49 "amplification"
"102" "TARGET-30-PARACS-01A-01D" "TARGET-30-PARACS-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 41.99 "neutral"
"103" "TARGET-30-PARAMT-01A-01D" "TARGET-30-PARAMT-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 3 84.91 "neutral"
"104" "TARGET-30-PARBGP-01A-01D" "TARGET-30-PARBGP-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 64.79 "loss"
"105" "TARGET-30-PARDCK-01A-01D" "TARGET-30-PARDCK-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 9.06 "loss"
"106" "TARGET-30-PARDIW-01A-01D" "TARGET-30-PARDIW-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 27.17 "loss"
"107" "TARGET-30-PARFWB-01A-01D" "TARGET-30-PARFWB-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 39.63 "neutral"
"108" "TARGET-30-PARGKK-01A-01D" "TARGET-30-PARGKK-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 37.51 "neutral"
"109" "TARGET-30-PARKGJ-01A-01D" "TARGET-30-PARKGJ-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 11.58 "gain"
"110" "TARGET-30-PARSBI-01A-01D" "TARGET-30-PARSBI-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 14.69 "loss"
"111" "TARGET-30-PARVLK-01A-01D" "TARGET-30-PARVLK-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 13.46 "loss"
"112" "TARGET-30-PARYNK-01A-01D" "TARGET-30-PARYNK-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 6.28 "neutral"
"113" "TARGET-30-PARZIP-01A-01D" "TARGET-30-PARZIP-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 61.24 "loss"
"114" "TARGET-30-PASCDX-01A-01D" "BS_97SKFHM4" "MYCN" "Neuroblastoma" "MYCN amp" 106 171.07 "amplification"
"115" "TARGET-30-PASEGA-01A-01D" "TARGET-30-PASEGA-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 19.7 "neutral"
"116" "TARGET-30-PASFGG-01A-01D" "TARGET-30-PASFGG-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 22.7 "neutral"
"117" "TARGET-30-PASGAP-01A-01D" "TARGET-30-PASGAP-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 6.4 "loss"
"118" "TARGET-30-PASGUT-01A-01D" "TARGET-30-PASGUT-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 25.36 "loss"
"119" "TARGET-30-PASMJG-01A-01D" "TARGET-30-PASMJG-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 1.99 "neutral"
"120" "TARGET-30-PASMNT-01A-01D" "TARGET-30-PASMNT-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 53.58 "neutral"
"121" "TARGET-30-PASNEF-01A-01D" "TARGET-30-PASNEF-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 38.07 "loss"
"122" "TARGET-30-PASNZU-01A-01D" "TARGET-30-PASNZU-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 152 1197.28 "amplification"
"123" "TARGET-30-PASPER-01A-01D" "TARGET-30-PASPER-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 16.46 "neutral"
"124" "TARGET-30-PASRFS-01A-01D" "TARGET-30-PASRFS-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 51.69 "neutral"
"125" "TARGET-30-PASSRN-01A-01D" "TARGET-30-PASSRN-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 522 836.66 "amplification"
"126" "TARGET-30-PASSRS-01A-01D" "TARGET-30-PASSRS-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 21.15 "loss"
"127" "TARGET-30-PASTCN-01A-01D" "TARGET-30-PASTCN-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 41.76 "loss"
"128" "TARGET-30-PASTKC-01A-01D" "TARGET-30-PASTKC-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 27.41 "loss"
"129" "TARGET-30-PASUCB-01A-01D" "TARGET-30-PASUCB-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 12.61 "loss"
"130" "TARGET-30-PASUYG-01A-01D" "TARGET-30-PASUYG-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 9.05 "neutral"
"131" "TARGET-30-PASVRU-01A-01D" "TARGET-30-PASVRU-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 121 553.88 "amplification"
"132" "TARGET-30-PASWFB-01A-01D" "TARGET-30-PASWFB-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 195 1168.07 "amplification"
"133" "TARGET-30-PASWIJ-01A-01D" "TARGET-30-PASWIJ-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 63.29 "neutral"
"134" "TARGET-30-PASWVY-01A-01D" "TARGET-30-PASWVY-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 4 86.39 "gain"
"135" "TARGET-30-PASWYR-01A-01D" "BS_MPE34NYZ" "MYCN" "Neuroblastoma" "MYCN amp" 138 334.91 "amplification"
"136" "TARGET-30-PASWYR-01A-01D" "TARGET-30-PASWYR-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 138 1165.28 "amplification"
"137" "TARGET-30-PASXGP-01A-01D" "TARGET-30-PASXGP-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 61.36 "neutral"
"138" "TARGET-30-PASXHE-01A-01D" "BS_EZRVK9ZQ" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 29.28 "gain"
"139" "TARGET-30-PASXHE-01A-01D" "TARGET-30-PASXHE-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 82.16 "gain"
"140" "TARGET-30-PASXIE-01A-01D" "BS_9TKGBJH7" "MYCN" "Neuroblastoma" "MYCN amp" 3 485.27 "gain"
"141" "TARGET-30-PASXIE-01A-01D" "TARGET-30-PASXIE-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 3 1399.01 "gain"
"142" "TARGET-30-PASXRG-01A-01D" "BS_9JBYGRQW" "MYCN" "Ganglioneuroblastoma" "MYCN amp" 14 163.86 "amplification"
"143" "TARGET-30-PASXRG-01A-01D" "TARGET-30-PASXRG-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN amp" 14 306.49 "amplification"
"144" "TARGET-30-PASXRG-01A-01D" "BS_9JBYGRQW" "MYCN" "Ganglioneuroblastoma" "MYCN amp" 4 163.86 "gain"
"145" "TARGET-30-PASXRG-01A-01D" "TARGET-30-PASXRG-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN amp" 4 306.49 "gain"
"146" "TARGET-30-PASXRG-01A-01D" "BS_9JBYGRQW" "MYCN" "Ganglioneuroblastoma" "MYCN amp" 14 163.86 "amplification"
"147" "TARGET-30-PASXRG-01A-01D" "TARGET-30-PASXRG-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN amp" 14 306.49 "amplification"
"148" "TARGET-30-PASXRG-01A-01D" "BS_9JBYGRQW" "MYCN" "Ganglioneuroblastoma" "MYCN amp" 4 163.86 "gain"
"149" "TARGET-30-PASXRG-01A-01D" "TARGET-30-PASXRG-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN amp" 4 306.49 "gain"
"150" "TARGET-30-PASXRJ-01A-01D" "BS_1BKHK7AY" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 12.66 "neutral"
"151" "TARGET-30-PASXRJ-01A-01D" "TARGET-30-PASXRJ-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 40.16 "neutral"
"152" "TARGET-30-PASYPX-01A-01D" "TARGET-30-PASYPX-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 35.42 "neutral"
"153" "TARGET-30-PASZPI-01A-01D" "TARGET-30-PASZPI-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 44 1114.27 "amplification"
"154" "TARGET-30-PATBMM-01A-01D" "BS_3DJBSNGE" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 11.39 "loss"
"155" "TARGET-30-PATBMM-01A-01D" "TARGET-30-PATBMM-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 18.62 "loss"
"156" "TARGET-30-PATCFL-01A-01D" "BS_N05R3CT2" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 2.91 "neutral"
"157" "TARGET-30-PATCFL-01A-01D" "TARGET-30-PATCFL-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 7.7 "neutral"
"158" "TARGET-30-PATDWN-01A-01D" "TARGET-30-PATDWN-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 238 1794.12 "amplification"
"159" "TARGET-30-PATDXC-01A-01D" "TARGET-30-PATDXC-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 66.34 "neutral"
"160" "TARGET-30-PATDXG-01A-01D" "TARGET-30-PATDXG-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 118 1668.97 "amplification"
"161" "TARGET-30-PATEKG-01A-01D" "TARGET-30-PATEKG-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 6.18 "neutral"
"162" "TARGET-30-PATEPF-01A-01D" "TARGET-30-PATEPF-01A-01R" "MYCN" "Ganglioneuroblastoma" "MYCN non-amp" 2 48.17 "neutral"
"163" "TARGET-30-PATESI-01A-01D" "TARGET-30-PATESI-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 105 1468 "amplification"
"164" "TARGET-30-PATFCY-01A-01D" "TARGET-30-PATFCY-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 73.78 "loss"
"165" "TARGET-30-PATFXV-01A-01D" "TARGET-30-PATFXV-01A-01R" "MYCN" "Neuroblastoma" "MYCN amp" 188 1768.19 "amplification"
"166" "TARGET-30-PATGLU-01A-01D" "TARGET-30-PATGLU-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 3 56.8 "gain"
"167" "TARGET-30-PATHVK-01A-01D" "TARGET-30-PATHVK-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 4 29.58 "neutral"
"168" "TARGET-30-PATINJ-01A-01D" "TARGET-30-PATINJ-01A-01R" "MYCN" "Neuroblastoma" "MYCN non-amp" 2 64.06 "neutral"
